Market Trends Stories
Will Byrna Technologies (USA Stocks:BYRN) shadow Ducommun Incorporated price boost?
 | few days ago at Macroaxis By Rifka Kats |
Fortune favors the bold, and Byrna Technologies might just be gearing up for a bold move in the stock market. With a market capitalization of $378.4M and a strong buy consensus from analysts, the company is drawing attention in the industrial machinery sector. Despite a slight dip in cash flow from $20.5M to $16.8M, Byrna's operating margin of 14.63% and a profit margin of 14.92% suggest a solid financial footing. Continue Reading...
- BYRN Byrna Technologies
- BYRN 14.96 -0.9
- Low 13.68
- High 15.05
- Alpha -0.89
- Beta -0.24
- Return On Equity 0.26
- Return On Asset 0.0671
- Profit Margin 0.15 %
- Operating Margin 0.15 %
- Current Valuation 318.05 M
- Shares Outstanding 22.67 M
- Shares Owned By Insiders 20.87 %
- Shares Owned By Institutions 52.69 %
- Number Of Shares Shorted 2.8 M
- Price To Earning (7.53) X
- Price To Book 6.27 X
- Price To Sales 3.95 X
- Revenue 85.76 M
- Gross Profit 52.77 M
- EBITDA 6.67 M
- Net Income 12.79 M
- Cash And Equivalents 24.46 M
- Cash Per Share 1.10 X
- Total Debt 2.64 M
- Debt To Equity 0.05 %
- Current Ratio 5.22 X
- Book Value Per Share 2.42 X
- Cash Flow From Operations 11.74 M
- Short Ratio 4.50 X
- Earnings Per Share 0.35 X
- Target Price 35.63
- Number Of Employees 167
- Beta 2.18
- Market Capitalization 339.1 M
- Total Asset 71.92 M
- Retained Earnings (56.78 M)
- Working Capital 35.52 M
- Current Asset 2.04 M
- Current Liabilities 2.89 M
- Net Asset 71.92 M
- Accumulation Distribution 0.091
- Daily Balance Of Power (0.66)
- Rate Of Daily Change 0.94
- Day Median Price 14.37
- Day Typical Price 14.56
- Market Facilitation Index 1.37
- Price Action Indicator 0.15
- Period Momentum Indicator (0.90)
- Relative Strength Index 35.67
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
Out of sight, out of mind—a saying that seems to capture the current sentiment around MicroAlgo (MLGO) as investors shift their gaze towards MariaDB (MRDB). With MicroAlgo's quarterly earnings growth plummeting by 90% and a concerning profit margin of 35% loss, the company seems to be losing its appeal. Despite having a healthy cash reserve of $47.4M, the negative return on assets at 0.11 and a hefty earnings share loss of 188.97 paint a challenging picture.
| over a week ago at Macroaxis By Raphi Shpitalnik |  |
To evaluate Gold Royalty Corp's stock, you can compare its performance with Platinum by examining key indicators. This comparison helps assess how market fluctuations impact their prices and whether combining them in a portfolio could reduce risk. A potential strategy is to pair a long position in Platinum with a short position in Gold Royalty.
| over a week ago at Macroaxis By Gabriel Shpitalnik |  |
In the realm of biotechnology, innovation is the lifeblood that fuels progress. Sutro Biopharma, a player in the oncology sector, is making waves with its cutting-edge approach to developing antibody drug conjugates. With a market capitalization of $64.2 million, this company is not just another name in the biotech industry; it's a potential game-changer.
| over a week ago at Macroaxis By Nico Santiago |  |
With FactSet Research Systems (FDS) showing a negative Treynor Ratio of -0.25 and a Jensen Alpha of -0.09, investors might be cautious about its risk-adjusted returns, especially when considering its market capitalization of 16.7B. Given these metrics, some private investors might find the potential upside of 1.78% less enticing compared to other opportunities.
Main Ideas
By examining the fundamental indicators of FactSet Research and Dun, you can assess how market fluctuations impact their stock prices and determine if combining them in a portfolio might reduce risk. Pair trading strategies could be employed by taking a long position in Dun and a short position in FactSet Research.| over two weeks ago at Macroaxis By Vlad Skutelnik |  |
Artificial intelligence is steadily transforming business operations, streamlining workflows, and influencing decision-making in profound ways. From automating document management to optimizing supply chains, AI presents many great advantages, particularly in improving efficiency. However, challenges like energy consumption, security risks, and integration hurdles persist. This article explores how businesses—large and small—are adapting to AI-driven transformations, tackling drawbacks, and making use of emerging innovations to remain competitive.
| over two weeks ago at Macroaxis By Nico Santiago | |
Timing can be everything, especially when it comes to investing in the stock market. For those considering adding Schnitzer Steel Industries (SCHN) to their portfolio, there's a lot to consider beyond just its position in the metals and mining sector. With a revenue of $2.7 billion and a quarterly revenue growth of negative 2%, the company has faced its share of challenges.
| over three weeks ago at Macroaxis By Aina Ster |  |
The crypto market moves fast. One moment, a coin is unknown, and the next, it's making headlines with a swarm of happy investors around it. But how do you spot truly profitable assets before their prices skyrocket?
| over three weeks ago at Macroaxis By Aina Ster | |
Not all that glitters is gold, especially when it comes to the volatile world of biotech stocks like Tonix Pharmaceuticals. With a market cap of $81.8M and a hefty total cash outflow from operations of 102M, the company faces significant financial challenges. Despite having 24.9M in cash and short-term investments, the return on assets sits at a disappointing -0.44, highlighting inefficiencies in asset utilization.
| over three weeks ago at Macroaxis By Gabriel Shpitalnik | |
Box Inc. (NYSE: BOX) presents an intriguing case for investors looking to explore opportunities in the technology sector, specifically within application software. With a current typical price hovering around $32.75, Box's stock is closely aligned with its 50-day moving average, suggesting a period of relative stability. However, the company's financials reveal some areas of concern.
| over a month ago at Macroaxis By Aina Ster | |